José Antonio García Erce: A Shared Responsibility in Transfusion Medicine
José Antonio García Erce, Director of the Donation Center, Navarre Health Service (Osasunbidea), shared Katrina Snow’s post on LinkedIn:
“Plasma is possibly the scarcest blood component at that time and yet with the highest rate of inadequate transfusion.
The INR/INR does not predict the risk of bleeding, and is not validated to monitor or indicate treatment in non-anticoagulated patients.
It would only be validated for monitoring treatment with oral anti-vitamin K anticoagulants.”
Katrina Snow, Transfusion Safety Officer at North York General Hospital, shared a post on LinkedIn:
“I love this video from Choosing Wisely Canada highlighting Transfusion Medicine Recommendation number 3:
Don’t transfuse plasma to correct a mildly elevated INR (less than 1.8) or aPTT before a procedure.
Plasma is liquid gold.
In Canada, we currently use more plasma than we produce, making us heavily reliant on imported plasma to meet patient needs.
Every unit represents a precious, generously donated resource that should be used thoughtfully and according to evidence-based practice.
Appropriate plasma utilization isn’t just about avoiding unnecessary transfusions, it’s about protecting patients, stewarding a limited resource, and helping ensure a sustainable plasma supply for the future.”
Stay updated with Hemostasis Today.
-
Jul 29, 2026, 16:30Mostafa Faisal: Impact of DNMT3A and TET2 Mutations on Clotting and Bleeding in PV and ET
-
Jul 29, 2026, 16:01Gerardo Moscatelli: The Spike Protein Cascade – From Endothelial Binding to Vascular Collapse
-
Jul 29, 2026, 15:42Julie Cardoso: FDA Clears the First AI-Guided Ultrasound Software for Suspected DVT
-
Jul 29, 2026, 15:26Ahmad Alkhammash: Completing an Advanced Fellowship in Adult Thrombosis Medicine
-
Jul 29, 2026, 15:13Yara Mahmoud: The Molecular Basis in Hematology
-
Jul 29, 2026, 15:11Louisa Jorm: A New Era of Dynamic Cardiovascular Risk Assessment
-
Jul 29, 2026, 15:04Filippo Consonni: Treatment Strategies for Hematologic Immune Dysregulation in Inborn Errors of Immunity
-
Jul 29, 2026, 14:53Samer Alsaid: Warfarin Outcomes Reassessed Through COMBINE AF
-
Jul 29, 2026, 14:46François Saller: TFPI-Targeting VHHs for Haemophilia and Rare Bleeding Disorders